Cargando…
A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer
Programmed cell death 1 ligand (PD-L1) blockade has been used therapeutically in the treatment of ovarian cancer, and potential combination treatment approaches are under investigation to improve the treatment response rate. The increased dependence on glutamine is widely observed in various type of...
Autores principales: | Wang, Jing-Jing, Siu, Michelle Kwan-Yee, Jiang, Yu-Xin, Leung, Thomas Ho-Yin, Chan, David Wai, Wang, Huo-Gang, Ngan, Hextan Yuen-Sheung, Chan, Karen Kar-Loen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698585/ https://www.ncbi.nlm.nih.gov/pubmed/34944392 http://dx.doi.org/10.3390/biom11121749 |
Ejemplares similares
-
Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer
por: Jiang, Yu-Xin, et al.
Publicado: (2020) -
Role of Nurr1 in Carcinogenesis and Tumor Immunology: A State of the Art Review
por: Wan, Peter Kok-Ting, et al.
Publicado: (2020) -
CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma
por: Mo, Xue-Tang, et al.
Publicado: (2020) -
Tamoxifen use in recurrent ovarian cancer in a Chinese population: A 15 ‐year clinical experience in a tertiary referral center
por: Chan, Karen Kar Loen, et al.
Publicado: (2020) -
Differentiation of aggressive and indolent subtypes of uterine sarcoma using maximum standardized uptake value
por: Lee, Elaine Yuen Phin, et al.
Publicado: (2013)